New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor Address
Published Date: 2/6/2026
Rule
Summary
The FDA updated rules for new animal drugs approved between July and September 2025, including approvals, withdrawals, and sponsor changes. These updates affect drug makers, vets, and farmers by keeping drug info accurate and easy to find. The changes take effect February 6, 2026, helping everyone stay on the same page without extra costs.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
New drug use and withdrawal limits
The rule adds specific conditions of use for certain drugs. For doramectin in cattle, you may not slaughter treated cattle for human consumption within 35 days of treatment, it is not for use in female dairy cattle 20 months of age or older, no withdrawal period is established for preruminating calves, and do not use in calves to be processed for veal. For fluralaner oral solution in chickens, treated chickens must not be slaughtered for human consumption for 11 days after the last treatment, and no egg discard is required when used according to labeling.
Animal drug rules updated (July–Sept 2025)
The FDA amended animal drug regulations to reflect approvals, withdrawals, and sponsor changes for new animal drug applications during July, August, and September 2025. The rule is effective February 6, 2026. FDA says these updates affect drug makers, veterinarians, and farmers by keeping drug information accurate and easy to find and that the changes take effect without extra costs.
Fluralaner food-residue limits set
FDA established an acceptable daily intake (ADI) for total fluralaner residue of 10 micrograms per kilogram of body weight per day and tolerances for parent fluralaner in chickens: liver 320 ppb, muscle 110 ppb, and eggs 2500 ppb. These tolerances are tied to the fluralaner chicken use described in Sec. 520.999.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-18529, Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Tracking
The FDA wants your thoughts on how they collect info to track medical devices. This affects companies that make or handle these devices and aims to keep things safe and clear. You’ve got until November 10, 2026, to share your comments—no cost, just your voice!
2026-18612, Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software
The Food and Drug Administration (FDA) is classifying the cardiovascular machine learning-based notification software into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the cardiovascular machine learning- based notification software. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
2026-18551, Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Salicylate
The Food and Drug Administration (FDA or Agency) is announcing the availability on its website of the final administrative order (final order) (OTC000008-1) titled "Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Salicylate." This final order amends "Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use" (Over- the-Counter (OTC) Monograph M020) to remove PABA and trolamine salicylate as sunscreen active ingredients. A sunscreen drug product containing PABA or trolamine salicylate is not generally recognized as safe and effective (GRASE).
Previous / Next Documents
Previous: 2026-02326, Appellate Procedures for the Board of Immigration Appeals
Starting March 9, 2026, the Board of Immigration Appeals will change how it reviews cases from Immigration Judges. Now, the Board can choose which cases to review fully, set clear deadlines for briefs, and speed up decisions to cut down the backlog. These updates affect immigrants appealing decisions and aim to make the process faster without extra costs.
Next: 2026-02335, Safety Zone; Chicago Sanitary and Ship Canal, Chicago, IL
From February 7 to 22, 2026, the Coast Guard will block off a 2-mile stretch of the Chicago Sanitary and Ship Canal for electric fish barrier testing. Boats can’t enter or anchor there during certain morning and afternoon hours unless they get special permission. This keeps everyone safe while the testing happens, so plan your trips accordingly!